The cornerstone of the government's plan to reform the provincial drug system is the Transparent Drug System for Patients Act 2006, which received Royal Assent on June 20, 2006.

The Act sets out principles of good drug system governance that are enshrined in the legislation :

• Striving to meet the needs of Ontarians, as patients, consumers and taxpayers;
• Involving consumers and patients in a meaningful way;
• Operating transparently, to the extent possible, for all persons with an interest in the system, including, without being limited to, patients, health care practitioners, consumers, manufacturers, wholesalers and pharmacies;
• Aiming to consistently achieve value-for-money and ensure the best use of resources at every level of the system;
• Making funding decisions for drugs on the best clinical and economic evidence available, communicating those decisions openly, in as timely a manner as possible.

See also :

• Appointment of an Executive Officer Progress
• Patient Representatives on the Committee to Evaluate Drugs Progress
• Pharmacy Council Progress
• Citizens' Council Progress